To win the battle against the pandemic, kids will be vital.
The fight against COVID-19 has long been focused on adults – particularly older adults. But kids are becoming a more prominent part of the conversation. We likely won’t see an end to the pandemic, experts say, until children can get vaccinated.
On Wednesday, Pfizer and its partner BioNTech announced the results of its coronavirus vaccine trial in adolescents 12 to 16 years old. It’s safe and effective in that age group, the company reported. The Pfizer-BioNTech vaccine currently is approved for emergency use by the FDA for ages 16 and up, and extending use to that younger age group will take a separate approval process. In March, both Pfizer and Moderna announced that they have begun trials of their respective COVID-19 vaccines in children under the age of 12 and as young as six months. Moderna also has a vaccine trial underway in adolescents.
“Children and adolescents will play a key role in ultimately closing that last part of the gap to help us emerge from this pandemic,” says Neil Maniar, associate chair of the Department of Health Sciences at Northeastern.